Chateal Eq
Product Images NDC 53002-2683

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Chateal Eq (NDC 53002-2683). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022683)

Chateal EQ 150/30 mg tablet blister packaging label by RPK Pharmaceuticals, Inc., NDC 53002-2683. The label indicates a 28-tablet, 1-month supply with directions to take 1 tablet daily as directed. The label includes patient name and clinic information fields, lot number, expiration date, and billing information. The product is marked Rx only.*

FDA Label Image

Figure 1: Likelihood Of Developing A Vte (Levo Ethi Fig1)

A horizontal bar chart illustrating the number of women with a blood clot out of 10,000 woman years (WY) across four groups: Non-Pregnant Non-COC users, COC users, Pregnancy, and Postpartum (12 weeks only). The chart displays ranges for each group, with postpartum showing the highest range (40 to 65), followed by pregnancy (5 to 20), COC users (3 to 9), and non-pregnant non-COC users (1 to 5). Pregnancy data includes a footnote regarding duration assumptions.*

FDA Label Image

Figure2 (Levo Ethi Fig2)

An illustration showing categories of birth control methods organized by effectiveness, measured as pregnancies per 100 women per year. The chart ranges from fewer pregnancies (fewer than 1 per 100) with implants, injections, intrauterine devices, and sterilization, to more pregnancies (85 or more per 100) with no birth control. Intermediate effectiveness methods include birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, and less effective methods like no sex during fertile days, spermicide, and withdrawal.*

FDA Label Image

Figure A (Levo Ethi Fig3)

An instructional diagram labeled Figure A showing a weekly pill schedule for Chateal EQ (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.15 mg/0.03 mg. It displays four rows representing four weeks: the first three rows labeled Orange and the fourth row Green, with seven circular pill icons each corresponding to days Sunday through Saturday. Storage instructions note to keep at 20° to 25°C (68° to 77°F). The NDC 50102-230-01 is shown in the top right corner.*

FDA Label Image

Chemical Structure1 (Levo Ethi Str1)

Chemical structure of Levonorgestrel with molecular formula C21H28O2 and molecular weight 312.4. The diagram shows the steroid backbone with functional groups including an alkyne and hydroxyl group.*

FDA Label Image

Chemical Structure2 (Levo Ethi Str2)

Chemical structure diagram of Ethinyl Estradiol, displaying the molecular arrangement and chemical bonds. The formula C20H24O2 and molecular weight 296.4 are noted below the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.